NL-OMON41442已完成不适用
[PETDE10] Imaging of phosphodiesterase 10 A (PDE10A) enzyme levels in the living human brain of Huntington*s disease gene expansion carriers and healthy controls with positron emission tomography - PET-study PDE10A
CHDI foundation0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Age 18 to 70 years, inclusive;- (HCs): Healthy according to medical history, physical examination, ECG, vital signs, laboratory assessment and MRI, with a body mass index between 19 and 27 (both inclusive);- HDGECs: Otherwise healthy according to medical history, no comorbidity of psychotic disorders, physical examination, vital signs and laboratory assessments, and with a body mass index (BMI) between 19 and 27 (both inclusive)
- •- (HDGECs): (A) HD Stage 1 or HD Stage 2: Patients with a clinical diagnosis of HD, defined by the presence of noticeable motor disorder and *36 CAG repeats (HD stage 1: TFC 11-13, HD stage 2: TFC 7-10); (B) Pre-manifest: Subjects that are carriers of the mutant Huntington gene with *40 CAG repeats, a Total Motor Score *5 and disease burden score of either * 250 (early pre-manifest) or a disease burden score * 275 (late pre-manifest); disease burden score is calculated with the equationa ((CAGn-35.5) X age))
排除标准
- •- HDGECs and HCs: Any disease, condition, or concomitant medication that significantly compromises the function of the body systems and that in the opinion of the Investigator might interfere with the conduct of the study or its interpretation.;- History of anaphylactoid or anaphylactic reactions to any allergen including drugs and contrast media.;- Contraindication to MRI, such as known claustrophobia, presence of metal devises or implants (e.g. pacemaker, vascular- or heart- valves, stents, clips), metal deposited in the body (e.g. bullets or shells), or metal grains in the eyes.;- HDGECs: History of other neurological condition (including brain surgery, intracranial haematoma, stroke/cerebrovascular disorders, epilepsy), co-morbidity of psychotic disorders.;- HCs: Family history of HD.
研究者
相似试验
已完成
早期 1 期
[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.Huntington's DiseaseNCT02061722CHDI Foundation, Inc.90
已完成
1 期
An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063Healthy VolunteersNCT02370602Takeda13
已完成
早期 1 期
Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion CarriersHuntington's DiseaseNCT02956148CHDI Foundation, Inc.45
已完成
不适用
Central PDE10A status in the clinical manifestation of schizophreniaschizophreniaJPRN-UMIN000029111ational Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology54
撤回
1 期
An imaging study of 64Cu-SARTATE using positron emission tomography in paediatric patients with high-risk neuroblastoma.ACTRN12617001259336Clarity Pharmaceuticals LTD10
